Monday, August 16, 2010

Death Panel

When is a Death Panel not unlike a Death Squad? I fear we'll be finding out soon.

The FDA is thinking about revoking the sale of the world's best selling and very expensive drug Avastin for advanced breast cancer treatment. If it does it will mark the start of 'death panel' drug rationing and debate over U.S. health care reform and how much the government should spend on expensive treatments.

About 18,000 women take the drug at a cost of $8,000 per month or more. Initial life was extended more than 5 months, but new studies indicate less.
Good for coffin sales - one of the
few things still made in the U.S.

The FDA has decided to drop the endorsement for breast cancer treatment. Usually the FDA cites effectiveness when they drop some drug. The real reason here just ahead of Obamacare reforms is cost  in which the government will extend health insurance to the poorest.

If the drug is not kept on the approval list by the FDA then medical insurance companies will stop paying for Avastin. David Vitter, the Republican Senator for Louisiana, said the FDA decision amounted to rationing health care.

This is the start of evidence that Obama’s overhaul of the health care system forcing many to be denied treatments currently available if deemed too expensive are true.

They do this kind of crap in Britain - withholding treatment from a patient simply because their life is not deemed valuable enough.

A final decision will be made shortly. Expect more to come under Obamacare.

Idioci w naszym rządzie. Idź do piekło. Jesteś zabicie tego kraju.

.

No comments:

Post a Comment